{
    "nctId": "NCT00078000",
    "briefTitle": "A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.",
    "officialTitle": "A Phase 2 Study Of The Efficacy And Safety Of SU011248 In Patients With Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 64,
    "primaryOutcomeMeasure": "Anti-tumor efficacy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Anthracycline and taxane-refractory or intolerant metastatic breast cancer\n* Female\n\nExclusion Criteria:\n\n* Prior treatment with 3 or greater regimens of chemotherapy in the advanced/metastatic disease setting beyond those containing anthracyclines/taxanes.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}